John Block

“So, Jeff or Bobby, the 8% organic constant currency is roughly $100 million of dollar growth, if I've got that correct, year-over-year. You called out Zendralia and CQ as the two biggest drivers of that $100 million.”

“Mike, maybe you could talk a little bit more about these commercial investments that you called out. You know, they've certainly yielded good returns in the past, but why now for the next tranche?”

“We're welcomed by the company's EVP of Corporate Strategy and CEO-designate Danny Bentheim, Glenn David, CFO, and COO Larry Miller. I'm going to turn it over to the Fibro team.”

“I'll pivot to the business a little bit, and you guys had a solid first quarter. On the earnings call, you called out the U.S. dental market remaining healthy into April, and clearly investors are worried about the consumer confidence.”

“You know, Wendy, I believe you said the channel's now normalized. You know, I do think that U.S. pet health number surprised everyone. So, is there a way of calling out the impact in 1Q26 from the channel, what that was specific to U.S. Pet Health.”